A new study of long-term outcomes in primary angiitis of the central nervous system suggests that mortality is significant, but long-term disability is mild. Dr. Rula Hajj-Ali describes her research efforts and the need for prognostic markers.
The distinct microbiome found in patients with aortitis may help researchers determine the etiology of the disease.
This is the longest reported follow-up of patients with PACNS and the first evaluation of the quality of life and incidence of depression in these patients.
Contrasting results raise interesting questions about these diseases and highlight the importance of continued research in vasculitis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A training infrastructure for our rheumatology fellows provides a full circle experience of evidence-based, didactic learning and its application to the direct care of patients with vasculitis.
The treatment of vasculitis has evolved significantly over the past 20 years, in some instances providing physicians and patients with a diverse range of options. With these options come questions of when to use these different therapies and how to weigh their risks and benefits.
Leonard Calabrese, DO, Director of the RJ Fasenmyer Center for Clinical Immunology, reflects on breakthroughs in vasculitis at the 2016 American College of Rheumatology meeting.
This case study of recent dyspnea in a patient with granulomatosis with polyangiitis (Wegener’s) shows the value a multidisciplinary approach brings to vasculitis management.
Two highly distinct case vignettes demonstrate that multidisciplinary expertise is essential to managing the acute life-threatening complications that vasculitis can pose.
Despite advances in treating granulomatosis with polyangiitis (GPA), 50 to 70 percent of patients experience relapses after remission induction. Reduction of those relapses is a need that this study aims to meet.